PCK2 and Hyperglycemia: A study previously reported that Orz reduced the risk of high-fat diet-induced hyperglycemia via regulation of insulin secretion as well as the activities of hepatic glucose-regulating enzymes such as G6Pase and phosphoenolpyruvate carboxykinase (PEPCK) [25].